answersLogoWhite

0

The research for CBT-1 has just completed phase III trials and is being reviewed for FDA approval. Dr Oldham was the primary researcher for this CBApharma investigation that should get approval.

User Avatar

Wiki User

14y ago

What else can I help you with?

Related Questions